Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick Berro Rivera

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
JACC. Advances|June 28, 2024
Sex Differences in Cardiovascular Outcomes and Cholesterol-Lowering Efficacy of PCSK9 Inhibitors: Systematic Review and Meta-AnalysisFrederick Berro Rivera, Sung Whoy Cha, John Paul Aparece, et al.
American Journal of Preventive Cardiology|July 3, 2026
Impact of incretin therapies on biochemical and imaging outcomes in metabolic dysfunction-associated steatotic liver diseaseNicole Ann Tesoro, Frederick Berro Rivera, Nathan Ross B Bantayan, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Cardiovascular Effects of Excess Growth Hormone: How Real is the Threat?Frederick Berro Rivera, Marianne Katharina Taliño, Marie Francesca Ansay, et al.
Glomerular Diseases|February 23, 2023
HIV-Associated Nephropathy in 2022Frederick Berro Rivera, Marie Francesca Mapua Ansay, Jem Marie Golbin, et al.
Expert Review of Cardiovascular Therapy|August 23, 2023
Sex differences in permanent pacemaker implantation after transcatheter aortic valve replacement: a systematic review and meta-analysisFrederick Berro Rivera, Sung Whoy Cha, John Paul Aparece, et al.
Journal of Clinical Lipidology|June 21, 2024
Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with and without diabetes mellitus: A meta-analysis of placebo-controlled randomized controlled trialsFrederick Berro Rivera, Nathan Ross B Bantayan, John Paul Aparece, et al.
The Canadian Journal of Cardiology|August 2, 2024
A Global Perspective on Socioeconomic Determinants of Cardiovascular HealthBart Wilder, Alejandro Pinedo, Salaheldin Abusin, et al.
Cardiorenal Medicine|February 21, 2023
Transcatheter Aortic Valve Replacement-Associated Acute Kidney Injury: An UpdateFrederick Berro Rivera, Abdullah Al-Abcha, Marie Francesca Mapua Ansay, et al.
Current Medical Research and Opinion|December 12, 2024
Glucagon-like peptide 1 receptor agonists modestly reduced low-density lipoprotein cholesterol and total cholesterol levels independent of weight reduction: a meta-analysis and meta-regression of placebo controlled randomized controlled trialsFrederick Berro Rivera, Marielle Nicole Cabusas Chin, Polyn Luz S Pine, et al.
Expert Review of Cardiovascular Therapy|January 29, 2024
Sex differences in trends and outcomes of acute myocardial infarction with mechanical complications in the United StatesFrederick Berro Rivera, Faye Salva, Jacques Simon Gonzales, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
JACC. Advances|June 28, 2024
Sex Differences in Cardiovascular Outcomes and Cholesterol-Lowering Efficacy of PCSK9 Inhibitors: Systematic Review and Meta-AnalysisFrederick Berro Rivera, Sung Whoy Cha, John Paul Aparece, et al.
American Journal of Preventive Cardiology|July 3, 2026
Impact of incretin therapies on biochemical and imaging outcomes in metabolic dysfunction-associated steatotic liver diseaseNicole Ann Tesoro, Frederick Berro Rivera, Nathan Ross B Bantayan, et al.
Reviews in Cardiovascular Medicine|July 30, 2024
Cardiovascular Effects of Excess Growth Hormone: How Real is the Threat?Frederick Berro Rivera, Marianne Katharina Taliño, Marie Francesca Ansay, et al.
Glomerular Diseases|February 23, 2023
HIV-Associated Nephropathy in 2022Frederick Berro Rivera, Marie Francesca Mapua Ansay, Jem Marie Golbin, et al.
Expert Review of Cardiovascular Therapy|August 23, 2023
Sex differences in permanent pacemaker implantation after transcatheter aortic valve replacement: a systematic review and meta-analysisFrederick Berro Rivera, Sung Whoy Cha, John Paul Aparece, et al.
Journal of Clinical Lipidology|June 21, 2024
Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with and without diabetes mellitus: A meta-analysis of placebo-controlled randomized controlled trialsFrederick Berro Rivera, Nathan Ross B Bantayan, John Paul Aparece, et al.
The Canadian Journal of Cardiology|August 2, 2024
A Global Perspective on Socioeconomic Determinants of Cardiovascular HealthBart Wilder, Alejandro Pinedo, Salaheldin Abusin, et al.
Cardiorenal Medicine|February 21, 2023
Transcatheter Aortic Valve Replacement-Associated Acute Kidney Injury: An UpdateFrederick Berro Rivera, Abdullah Al-Abcha, Marie Francesca Mapua Ansay, et al.
Current Medical Research and Opinion|December 12, 2024
Glucagon-like peptide 1 receptor agonists modestly reduced low-density lipoprotein cholesterol and total cholesterol levels independent of weight reduction: a meta-analysis and meta-regression of placebo controlled randomized controlled trialsFrederick Berro Rivera, Marielle Nicole Cabusas Chin, Polyn Luz S Pine, et al.
Expert Review of Cardiovascular Therapy|January 29, 2024
Sex differences in trends and outcomes of acute myocardial infarction with mechanical complications in the United StatesFrederick Berro Rivera, Faye Salva, Jacques Simon Gonzales, et al.
Pageof 4